Acquisition Announced
McKesson acquisition of Precision Medicine Group
US$2.3bn consideration
Announced 25 Aug 2026
Advisers
- Target
- Precision Medicine Group
- Acquirer
- McKesson
- Seller
- Blackstone
- Target based in
- United States (unverified)
- Buyer based in
- United States
- Seller based in
- United States
- Sector
- Clinical Trial Services
- Tags
- Clinical Trial Services, Pharma Services, Life Sciences
In the league tables
Similar deals
- Everest Clinical Research acquisition of Firma Data Services Sep 2026 · Clinical Trial Services
- SV Health Investors acquisition of EpiVax Apr 2026 · Pharma Services
- THL Partners acquisition of Celerion Apr 2026 · Pharma Services
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- Veristat acquisition of Certara Regulatory and Medical Writing business Apr 2026 · US$135m · Pharma Services
Sources
- 2026 Centerview Partners: Centerview as co-lead financial advisor to Precision and Blackstone on their sale to McKesson. centerviewpartners.com
- 2026 Centerview Partners: Centerview as co-lead financial advisor to Precision and Blackstone on its sale to McKesson centerviewpartners.com
- 25 Aug 2026 McKesson $2.25 billion acquisition of Precision Medicine Group davispolk.com
- 27 Aug 2026 Debevoise Advises Precision Medicine Group’s Management in the Company’s Approximately $2.25 Billion Sale to McKesson debevoise.com


